الفهرس 
AcknowledgementsOnly 14 pages are availabe for public view
 |  | from | 124 |  |  |
| | | from | 124 | | |
Abstract
The aim of the present study was to compare the effectiveness of single oral iron dose versus double oral iron dose on prevention of IDA in non-anemic obese pregnant women and to clarify the role of hepcidin level on those women. Finally; the maternal and fetal outcomes were also reported. The study was a randomized clinical trial conducted from 1st of October 2019 to 1st of October 2021 at Assiut Woman’s Health Hospital. It included pregnant woman in a singleton pregnancy between 12-14 weeks who had BMI between 30- 40 kg/m2 and normal CBC and iron study parameters. However; we excluded women who received recent blood transfusion or threatened miscarriage or known to have pathological blood loss. Also women who are intolerant to oral iron form or had a history of hematologic disorder and those who used iron, minerals, vitamins, or subjected to blood donation within the previous 3 months were also excluded. Finally; women with chronic medical diseases, chronic infection/inflammatory diseases or lactating were excluded.